These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8896537)

  • 1. Varicella vaccine: the Japanese experience.
    Asano Y
    J Infect Dis; 1996 Nov; 174 Suppl 3():S310-3. PubMed ID: 8896537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella vaccination in Japan: necessity of implementing a routine vaccination program.
    Ozaki T
    J Infect Chemother; 2013 Apr; 19(2):188-95. PubMed ID: 23483311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of varicella vaccine in Japan and future prospects.
    Ozaki T; Asano Y
    Vaccine; 2016 Jun; 34(29):3427-33. PubMed ID: 27160039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
    Ozaki T
    Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of breakthrough varicella observed in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain).
    Takayama N; Minamitani M; Takayama M
    Acta Paediatr Jpn; 1997 Dec; 39(6):663-8. PubMed ID: 9447754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic.
    Ozaki T; Nishimura N; Kajita Y
    Vaccine; 2000 May; 18(22):2375-80. PubMed ID: 10738094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview.
    Takahashi M
    Paediatr Drugs; 2001; 3(4):285-92. PubMed ID: 11354700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of Booster Vaccination in Children with Primary Vaccine Failure after Initial Varicella Vaccination].
    Ozakiv T; Nishimura N; Gotoh K; Funahashi K; Yoshii H; Okuno Y
    Kansenshogaku Zasshi; 2016 May; 90(3):291-6. PubMed ID: 27529963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicella and varicella vaccination in South Korea.
    Oh SH; Choi EH; Shin SH; Kim YK; Chang JK; Choi KM; Hur JK; Kim KH; Kim JY; Chung EH; Lee SY; Park SE; Cha S; Kim KN; Ma SH; Eun BW; Kim NH; Jo DS; Choi BY; Kim SA
    Clin Vaccine Immunol; 2014 May; 21(5):762-8. PubMed ID: 24671555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.
    Saiman L; LaRussa P; Steinberg SP; Zhou J; Baron K; Whittier S; Della-Latta P; Gershon AA
    Infect Control Hosp Epidemiol; 2001 May; 22(5):279-83. PubMed ID: 11428437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
    Freer G; Pistello M
    New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial.
    Dubey AP; Faridi MMA; Mitra M; Kaur IR; Dabas A; Choudhury J; Mukherjee M; Mishra D
    Hum Vaccin Immunother; 2017 Sep; 13(9):2032-2037. PubMed ID: 28509605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella vaccination of children in the United States: assessment after the first decade 1995-2005.
    Grose C
    J Clin Virol; 2005 Jun; 33(2):89-95; discussion 96-8. PubMed ID: 15911422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live attenuated varicella vaccine.
    Arvin AM; Gershon AA
    Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
    MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.